Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the long-term safety of alogliptin, once daily (QD),
following participation in 1 of 7 controlled studies in patients with type 2 diabetes
mellitus.